Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Safer proteinase treatment of sciatica. A biochemical preview of chymopapain inhibitors

Grubb, A LU orcid (1988) In Acta Orthopaedica Scandinavica 59(1). p.63-65
Abstract
As pointed out in the preceding review (Nachemson and Rydevik 1988), the most serious and common complications of chymopapain treatment of patients with sciatica due to disc herniation are cerebral or subarachnoid hemorrhages and allergic manifestations. Recent progress in biochemical and physiologic studies of cysteine proteinases and their inhibitors allows some speculation on how these complications in the future might be alleviated or avoided and on how the efficiency of proteinase treatment of patients with sciatica might be increased.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Chymopapain/adverse effects, Cysteine Endopeptidases, Cysteine Proteinase Inhibitors, Intervertebral Disc Displacement/drug therapy, Protease Inhibitors/therapeutic use, Sciatica/drug therapy
in
Acta Orthopaedica Scandinavica
volume
59
issue
1
pages
63 - 65
publisher
Taylor & Francis
external identifiers
  • scopus:0023899361
  • pmid:3281407
ISSN
0001-6470
DOI
10.3109/17453678809149347
language
English
LU publication?
yes
id
c23e3b4b-2007-4f60-8da8-c17cfc48482e
date added to LUP
2021-10-27 08:16:13
date last changed
2024-01-12 02:57:25
@article{c23e3b4b-2007-4f60-8da8-c17cfc48482e,
  abstract     = {{As pointed out in the preceding review (Nachemson and Rydevik 1988), the most serious and common complications of chymopapain treatment of patients with sciatica due to disc herniation are cerebral or subarachnoid hemorrhages and allergic manifestations. Recent progress in biochemical and physiologic studies of cysteine proteinases and their inhibitors allows some speculation on how these complications in the future might be alleviated or avoided and on how the efficiency of proteinase treatment of patients with sciatica might be increased.}},
  author       = {{Grubb, A}},
  issn         = {{0001-6470}},
  keywords     = {{Chymopapain/adverse effects; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Intervertebral Disc Displacement/drug therapy; Protease Inhibitors/therapeutic use; Sciatica/drug therapy}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{63--65}},
  publisher    = {{Taylor & Francis}},
  series       = {{Acta Orthopaedica Scandinavica}},
  title        = {{Safer proteinase treatment of sciatica. A biochemical preview of chymopapain inhibitors}},
  url          = {{http://dx.doi.org/10.3109/17453678809149347}},
  doi          = {{10.3109/17453678809149347}},
  volume       = {{59}},
  year         = {{1988}},
}